Impact of respiratory viral infections on pediatric inpatients with a respiratory disease after COVID‐19 restrictions
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 02.07.2025. Verfasst von Yo Murata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Tokyo Metropolitan Tama-Hokubu Medical Center, Higashimurayama, Japan. Hauptthemen laut MEDLINE: COVID-19, Respiratory Tract Infections, Asthma, Virus Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Non‐pharmaceutical interventions (NPIs) for the coronavirus disease 2019 (COVID‐19) pandemic altered the prevalence of respiratory viruses in Japan. The present, retrospective study aimed to investigate the prevalence of respiratory viruses in pediatric inpatients with a viral respiratory infection at a community hospital in Japan following the termination of NPIs for COVID‐19.
Methods
The present study, which enrolled pediatric inpatients who underwent multiplex PCR (FilmArray® respiratory panel) testing and were hospitalized for a lower respiratory tract infection (LRTI) or an acute exacerbation of bronchial asthma (BA), compared the rate of detection of respiratory viruses in these patients during the implementation of NPIs for COVID‐19 (December 2020–March 2022) and after their termination (April 2022–August 2023).
Results
Of 2011 patients, 503 with a LRTI and 175 with BA were included. During and after the COVID‐19 restriction period, 191 and 312 patients had a LRTI and 64 and 111 patients had BA, respectively. After the COVID‐19 restrictions were lifted, human metapneumovirus (hMPV) and parainfluenza virus (PIV) were more frequently detected among patients with a LRTI (hMPV: 0% vs. 15%; p < 0.001; PIV: 17% vs. 25%; p = 0.0499). Among the patients with BA, rhinoviruses and enteroviruses were most commonly detected during both periods.
Conclusions
The rate of hospitalization for LRTI or BA increased after the relaxation of NPIs. The rate of detection of hMPV and PIV significantly increased in patients with an LRTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Tokyo Metropolitan Tama-Hokubu Medical Center, Higashimurayama, Japan.
- Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
ORCID-Profile: Yo Murata, Yuya Saito, Yuho Horikoshi
Zitieren
APA
Murata, Y., Saito, Y., Horikoshi, Y., & Obonai, T. (2025). Impact of respiratory viral infections on pediatric inpatients with a respiratory disease after COVID‐19 restrictions. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70138
Vancouver
Murata Y, Saito Y, Horikoshi Y, Obonai T. Impact of respiratory viral infections on pediatric inpatients with a respiratory disease after COVID‐19 restrictions. Pediatrics International. 2025;67(1). doi:10.1111/ped.70138
BibTeX
@article{Murata2025,
author = {Murata, Yo and Saito, Yuya and Horikoshi, Yuho and Obonai, Toshimasa},
title = {Impact of respiratory viral infections on pediatric inpatients with a respiratory disease after COVID‐19 restrictions},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70138}
}
EUVIMED